◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Vaxil Bio Ltd.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 0.00 --
Selling General And Administration 32,000 37,000 70,000 31,000 44,000 --
General And Administrative Expense 32,000 37,000 70,000 31,000 44,000 --
Research And Development -- -- 4,000 2,000 3,000 -13,000
Operating Expense 32,000 37,000 74,000 33,000 44,000 --
Operating Income -32,000 -37,000 -74,000 -33,000 -44,000 --
EBIT -32,000 -37,000 -74,000 -33,000 -44,000 --
Interest Income 12,000 73,000 4,000 10,000 8,000 --
Interest Income Non Operating 12,000 73,000 4,000 10,000 8,000 --
Net Interest Income 12,000 73,000 4,000 10,000 8,000 --
Special Income Charges -- -- -- 0.00 0.00 --
Pretax Income -20,000 36,000 -70,000 -23,000 -36,000 --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -20,000 42,000 -70,000 -22,000 -49,000 --
Net Income From Continuing Operation Net Minority Interest -20,000 36,000 -70,000 -22,000 -36,000 --
Net Income Including Noncontrolling Interests -20,000 42,000 -70,000 -23,000 -49,000 --
Net Income Common Stockholders -20,000 42,000 -70,000 -22,000 -49,000 --
Net Income -20,000 42,000 -70,000 -22,000 -49,000 --
EBITDA -32,000 -37,000 -74,000 -33,000 -44,000 --
Normalized EBITDA -32,000 -37,000 -74,000 -33,000 -44,000 --
Basic EPS -0.01 0.02 -0.03 -- -0.02 0.00
Diluted EPS -0.01 0.02 -0.03 -- -0.02 0.00
Basic Average Shares 2.7M 2.7M 2.7M -- 2.7M 2.7M
Diluted Average Shares 2.7M 2.7M 2.7M -- 2.7M 2.7M
Total Unusual Items -- -- -- 0.00 0.00 --
Total Unusual Items Excluding Goodwill -- -- -- 0.00 0.00 --
Tax Rate For Calcs 0.00 0.15 0.00 0.00 0.00 --
Normalized Income -20,000 36,000 -70,000 -22,000 -36,000 --
Diluted NI Availto Com Stockholders -20,000 42,000 -70,000 -22,000 -49,000 --
Gain On Sale Of Ppe -- -- -- 0.00 0.00 --
Insurance And Claims -- -- 5,000 7,000 4,000 5,000
Net Income Continuous Operations -20,000 36,000 -70,000 -23,000 -36,000 --
Net Income Discontinuous Operations 0.00 6,000 -- -- -13,000 -7,000
Net Non Operating Interest Income Expense 12,000 73,000 4,000 10,000 8,000 --
Other Gand A 32,000 37,000 63,000 13,000 44,000 --
Rent And Landing Fees -- -- 2,000 11,000 3,000 1,000
Rent Expense Supplemental -- -- 2,000 11,000 3,000 1,000
Salaries And Wages 0.00 0.00 0.00 0.00 0.00 --
Total Expenses 32,000 37,000 74,000 33,000 44,000 --
Total Operating Income As Reported -32,000 -37,000 -74,000 -32,000 -44,000 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 447,000 347,000 403,000 448,000 535,000 --
Cash Cash Equivalents And Short Term Investments 447,000 347,000 403,000 448,000 535,000 --
Cash Financial -- -- -- -- 535,000 589,000
Other Short Term Investments -- -- -- -- -- 250,000
Accounts Receivable 12,000 12,000 15,000 -- 27,000 24,000
Receivables 156,000 278,000 281,000 273,000 285,000 --
Prepaid Assets -- -- -- 12,000 -- --
Current Assets 603,000 625,000 684,000 733,000 820,000 --
Investments And Advances 72,000 72,000 -- -- -- --
Total Non Current Assets 72,000 72,000 0.00 0.00 0.00 --
Total Assets 675,000 697,000 684,000 733,000 820,000 --
Payables And Accrued Expenses 8,000 6,000 40,000 17,000 82,000 --
Current Liabilities 8,000 6,000 40,000 17,000 82,000 --
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00 0.00 --
Total Liabilities Net Minority Interest 8,000 6,000 40,000 17,000 82,000 --
Common Stock 16.1M 16.1M 16.1M 16.1M 16.1M --
Capital Stock 16.1M 16.1M 16.1M 16.1M 16.1M --
Retained Earnings -19.6M -19.6M -19.6M -19.5M -19.5M --
Gains Losses Not Affecting Retained Earnings 4.2M 4.2M 4.2M 4.2M 4.2M --
Other Equity Adjustments 4.2M 4.2M 4.2M 4.2M 4.2M --
Common Stock Equity 667,000 691,000 644,000 716,000 738,000 --
Stockholders Equity 667,000 691,000 644,000 716,000 738,000 --
Total Equity Gross Minority Interest 667,000 691,000 644,000 716,000 738,000 --
Total Capitalization 667,000 691,000 644,000 716,000 738,000 --
Net Tangible Assets 667,000 691,000 644,000 716,000 738,000 --
Tangible Book Value 667,000 691,000 644,000 716,000 738,000 --
Working Capital 595,000 619,000 644,000 716,000 738,000 --
Invested Capital 667,000 691,000 644,000 716,000 738,000 --
Share Issued 2.7M 2.7M 2.7M 2.7M 2.7M --
Ordinary Shares Number 2.7M 2.7M 2.7M 2.7M 2.7M --
Notes Receivable 144,000 266,000 266,000 266,000 258,000 --
Taxes Receivable -- -- -- 7,000 -- --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -28,000 -52,000 -47,000 -84,000 -43,000 --
Cash Flow From Continuing Operating Activities -28,000 -52,000 -47,000 -84,000 -43,000 --
Stock Based Compensation 0.00 0.00 0.00 0.00 0.00 --
Change In Working Capital 4,000 -23,000 27,000 -52,000 1,000 --
Changes In Account Receivables -- -- 4,000 -- -- --
Change In Receivables 7,000 7,000 4,000 9,000 -4,000 --
Change In Payables And Accrued Expense -3,000 -30,000 23,000 -61,000 5,000 --
Other Non Cash Items -12,000 -73,000 -4,000 -10,000 -- --
Investing Cash Flow 127,000 -- -- 0.00 0.00 --
Cash Flow From Continuing Investing Activities 127,000 -- -- 0.00 0.00 --
Effect Of Exchange Rate Changes 1,000 -2,000 2,000 -3,000 2,000 --
Changes In Cash 99,000 -54,000 -47,000 -84,000 -56,000 --
Beginning Cash Position 347,000 403,000 448,000 535,000 589,000 --
End Cash Position 447,000 347,000 403,000 448,000 535,000 --
Free Cash Flow -28,000 -52,000 -47,000 -84,000 -43,000 --
Cash Flow From Discontinued Operation 0.00 -- -- -- -13,000 --
Net Income From Continuing Operations -20,000 44,000 -70,000 -22,000 -36,000 --
Net Other Investing Changes -- -- -- 0.00 0.00 --
NEWS
Loading news...
TRENDING
Loading...